Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Ovarian cancer vaccine enters pivotal trials in Europe

Nov. 8, 1996

Apoptosis-inducing MAb from Chugai

Nov. 8, 1996

MAb 1DT3-D disclosed for treatment of B-cell lymphoma

Oct. 25, 1996

HER2/neu peptide fragment provokes immune response against tumor cells

Oct. 18, 1996

Ovarian cancer vaccine enters phase II/III trials

Oct. 11, 1996

Patent coverage for The Immune Response Corporation's colon cancer vaccine

Oct. 11, 1996

Chemokine polypeptide from Human Genome Sciences has multiple potential uses

Oct. 11, 1996

Combination therapy Maxamine/IL-2 effective in extending remission time & preventing relapse

Oct. 4, 1996

Progenics cancer vaccine enters clinical trials

Oct. 4, 1996

Novopharm develops new recombinant form of MAb

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...